Shjnj Pharmaceutical Technologies Inc.

Idarubicin hydrochloride

• Category :

  Intermediates/Pharmaceutical intermediates

• Synonyms :

  Idarubicin Hydrochloride;(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside hydrochloride (1:1);(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride (1:1);(7S-cis)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-��-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride;

• CAS NO :

  57852-57-0

• EC NO :

  260-990-7

• Molecular Formula :

  C₂₆H₂₈ClNO₉

• Molecular Weight :

  533.9548

• Main Specifications :

• InChI :

  InChI=1/C26H27NO9.ClH/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31;/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3;1H/t10-,15-,16-,17-,21+,26-;/m0./s1

• Uses :

  It is an antileukemia drug.

• Molecular Structure :